Lupus nephritis in the absence of renal major histocompatibility complex class I and class II molecules

Journal of the American Society of Nephrology

Volumn 7, Issue 11, 1996, Pages 2445-2452

  Mukherjee, R ^a   Zhang, Z ^a   Zhong, R ^a   Yin, Z Q ^a   Roopenian, D C ^b   Jevnikar, A M ^a,c  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b JACKSON LABORATORY   (United States)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Gene deletion; Lupus nephritis; MHC molecules; MRL lpr; 2 microglobulin

Indexed keywords

AUTOANTIBODY; BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE DELETION; IMMUNOFLUORESCENCE; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0030357956     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Mountz JD, Cause WC: Murine models of autoimmune disease and Sjogren's syndrome. Curr Opin Rheumatol 1993;5:557-569.
2. Zhou T, Bluethmann H, Eldridge J, Berry K, Mountz JD: Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse. J Immunol 1993;150:3651-3667.
3. Mountz JD, Gause WC, Jonsson R: Murine models for systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol 1991;3:738-756.
4. Singer GG, Abbas AK: The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994;1:365-371.
5. Theofilopoulos AN, Dixon FJ: Etiopathogenesis of murine SLE. Immunol Rev 1981;55:179-216.
6. Wuthrich RP, Yui MA, Mazoujian G, Nabavi N, Glimcher LH, Kelley VE: Enhanced MHC class II expression in renal proximal tubules precedes loss of renal function in MRL/lpr mice with lupus nephritis. Am J Pathol 1989; 134:45-51.
7. Wuthrich RP: Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis. Kidney Int 1992;42:903-914.
8. Wuthrich RP, Jevnikar AM, Takei F, Glimcher LH, Kelley VE: Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis. Am J Pathol 1990;136:441-450.
9. Boswell JM, Yui MA, Burt DW, Kelley VE: Increased tumor necrosis factor and interleukin-1β gene expression in the kidneys of mice with lupus nephritis. J Immunol 1988;141:3050-3054.
10. Tsai CY, Wu TH, Huang SF, et al.: Abnormal splenic and thymic IL-4 and TNF-alpha expression in MRL-lpr/lpr mice. Scand J Immunol 1995;41:157-163.
11. Yokoyama H, Kreft B, Kelley VR: Biphasic increase in circulating and renal TNF-alpha in MRL-lpr mice with differing regulatory mechanisms. Kidney Int 1995;47: 122-130.
12. Cockfield SM, Ramassar V, Halloran PF: MRL mice with lupus nephritis have enhanced IFN-γ and TNF-α gene expression. Kidney Int 1989;37:223A.
13. Shlomchik MJ, Madaio MP, Ni D, Trounstein M, Huszar D: The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med 1994;180:1295-1306.
14. Itoh J, Takahashi S, Ono M, Yamamoto T, Nose M, Kyogoku M: Nephritogenic antibodies in MRL/lpr lupus mice: molecular characteristics in pathological and genetic aspects. Tohoku J Exp Med 1994;173:65-74.
15. Itoh J, Nose M, Takahashi S, et al.: Induction of different types of glomerulonephritis by monoclonal antibodies derived from an MRL/lpr lupus mouse. Am J Pathol 1993;143:1436-1443.
16. Vlahakos DV, Foster MH, Adams S, et al.: Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int 1992;41:1690-1700.
17. Jevnikar AM, Grusby MJ, Glimcher LH: Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med 1994;179:1137-1143.
18. Koh D-R, Ho A, Rahemtulla A, Fung-Leung W-P, Griesser H, Mak T-W: Murine lupus in MRL-lpr mice lacking CD4 or CD8 T cells. Eur J Immunol 1995;25: 2558-2562.
19. Christianson GJ, Blankenberg RL, Duffy TM, et al.: MHC class I dependence of lupus-like autoimmune syndrome of MRL-lpr mice. MHC class I dependence of the lupus-like syndrome of MRL-lpr mice. J Immunol 1996; 156:4932-4939.
20. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-317.
21. Singer GG, Carrera AC, Marshak RA, Martinez C, Abbas AK: Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model. Curr Opin Immunol 1994;6:913-920.
22. Zhang Z, Schlachta C, Duff J, Stiller CR, Grant D, Zhong R: Refined technique for kidney transplantation in mice. Microsurgery 1995;16:103-109.
23. Grusby MJ, Johnson RS, Papaioannou VE, Glimcher LH: Depletion of CD4+ T cells in Major Histocompatibility Complex class II deficient mice. Science 1991;253: 1417-1420.
24. Weston KM, Ju S-T, Lu CY, Sy M-S: Autoreactive T cells in MRL/Mp-lpr/lpr mice: Characterization of the lymphokine produced and analysis of antigen presenting cells required. J Immunol 1988;141:1941-1948.
25. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
26. Quan D, Grant DR, Zhong RZ, Zhang Z, Garcia BM, Jevnikar AM: Altered gene expression of cytokine, ICAM-1 and class II molecules precedes mouse intestinal allograft rejection. Transplantation 1994;58:808-816.
27. Mannon RB, Doyle C, Griffiths RC, Platt JL, Coffman TM: CD4+ T cell infiltrates are absent in class II deficient mouse renal allografts [Abstract]. J Am Soc Nephrol 1994;5:984.
28. Coffman T, Geier S, Ibrahim S, et al.: Improved renal function in mouse kidney allografts lacking MHC class I antigens. J Immunol 1993;151:425-435.
29. Jabs DA, Prendergast RA: Reactive lymphoctes in lacrimal gland and vasculitic renal lesions of autoimmune MRL/lpr mice express LT34. J Immunol 1987;166: 1198-1203.
30. Jabs DA, Burek CL, Hu Q, Kuppers RC, Lee B, Prendergast RA: Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice. Cell Immunol 1992;141:496-507.
31. Jabs DA, Kuppers RC, Saboori AM, et al.: Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr mice. Cell Immunol 1994;154:66-76.
32. Giese T, Davidson WF: Chronic treatment of C3H-lpr/ lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production. J Immunol 1994; 152:2000-2010.
33. Auchincloss Jr, H, Lee, R, Shea, S, Markowitz, JS, Grusby, MJ, Glimcher, LH: The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA 1993;90:3373-3377.
34. Grusby MJ, Auchincloss Jr., H, Lee, R, et al.: Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci USA 1993;90: 3913-3917.
35. Campos L, Naji A, Deli BC, et al.: Survival of MHC deficient mouse heterotopic cardiac allografts. Transplantation 1995;59:187-191.